期刊文献+

蛋白酶体抑制剂MG-132对肺癌A549细胞转分化的影响 被引量:1

Effect of proteasome inhibitor MG-132 on epithelial mesenchymal transition of A549 cells
下载PDF
导出
摘要 目的 探讨蛋白酶体抑制剂MG-132对肺癌A549细胞转分化的影响.方法 将肺癌A549细胞分为对照组(加入磷酸盐缓冲液)、T组[加入5 μg/L转化生长因子(TGF)-31]、M组(加入2.5μmol/LMG-132)、T+M组(加入2.5 μmol/L MG-132孵育30 min后再加入5μg/L TGF-31).倒置显微镜下观察各组培养24h后细胞形态的变化;采用免疫组织化学法检测各组细胞钙黏附蛋白E、波形蛋白、磷酸化Smad2/3蛋白及SnoN蛋白表达.结果 对照组细胞为上皮细胞所特有的铺路石样,T组细胞形态转变为梭形、纺锤形,T+M组与M组细胞形态同对照组比较无明显差异.T组钙黏附蛋白E表达明显低于对照组、M组及T+M组(0.144 ±0.046比0.347±0.019、0.352±0.020、0.332±0.017);波形蛋白及磷酸化Smad2/3蛋白表达明显高于对照组、M组及T+M组(0.483±0.063比0.130±0.034、0.134±0.015、0.166±0.011;0.367 1±0.016 9比0.073 3 ±0.000 6、0.071 3±0.000 8、0.108 5±0.002 2);SnoN蛋白表达高于对照组和M组(0.343 7±0.013 2比0.1530±0.0027、0.161 0±0.005 7).结论 MG-132可抑制TGF-β1诱导的A549细胞转分化,可能机制是MG-132下调磷酸化Smad2/3蛋白的表达以及上调SnoN蛋白的表达. Objective To investigate the effect of proteasome inhibitor MG-132 on epithelial mesenchymal transition in A549 cells.Methods The A549 cells were divided into:control group added with phosphate buffer,transforming growth factorβ1 (TGF-β1),stimulation group (T group) added with 5 μg/LTGF-β1,MG-132 group (M group) added with 2.5 μmol/L MG-132,MG-132 ± TGF-31 group (T ± M group) added with 2.5 μmol/L MG-132 followed by 5 μg/L TGF-31.The cellular morphology was observed by inverted phase-contrast microscope 24 h after treatment.Immunohistochemical technique was used to observe the expression of E-cadherin,Vimentin,p-Smad2/3 and SnoN.Results After being treated by TGF-β1 for 24 h,A549 cells in T group were found to turn to fusiform shape from pebble shape,no obvious changes were observed in T ± M group and M group compared with those in control group.The expression of E-cadherinin T group was significantly lower than that in control group,M group and T ± M group (0.144 ±0.046 vs 0.347 ±0.019,0.352 ±0.020,0.332 ±0.017),while the express of Vimentin and p-Smad2/3 showed the opposite tendency (Vimentin:0.483 ±0.063 vs 0.130 ±0.034,0.134 ± 0.015,0.166 ± 0.011;p-Smad2/3:0.367 1 ± 0.016 9 vs 0.073 3 ± 0.000 6,0.071 3 ± 0.000 8,0.108 5 ± 0.002 2).The expression of SnoN in T group was significantly higher than that in control group and M group (0.343 7 ±0.013 2 vs 0.153 0 ±0.002 7,0.161 0 ±0.005 7).Conclusion MG-132 can inhibit the epithelial mesenchymal transition of A549 cells,which can be related with the cs down-regulation of p-Smad2/3 protein expression and upregulation of SnoN protein.
出处 《中国医药》 2015年第7期1064-1066,共3页 China Medicine
基金 湖北省卫生厅科研基金(JX5858)
关键词 蛋白酶体抑制剂 A549细胞 上皮细胞-间质细胞转分化 Protease inhibitors A549 cell Epithelial-mesenchymal transition
  • 相关文献

参考文献14

  • 1Tai HC, Schuman EM. Ubiquitin, the proteasome and protein degradation in neuronal function and dysfunction[J]. Nat Rev Neurosci, 2008,9(11):826-838.
  • 2韩琳,陈慧,朱冰冰,靳远萌,王伟铭,陈楠.蛋白酶体抑制剂抑制肾间质成纤维细胞细胞外基质表达及其机制[J].肾脏病与透析肾移植杂志,2008,17(5):439-445. 被引量:5
  • 3Fineschi S, Bongiovanni M, Donati Y, et al. In vivo investigations on anti-fibrotic potential of proteasome inhibition in lung and skin fibrosis[J]. Am J Respir Cell Mol Biol, 2008,39(4):458-465.
  • 4Moreau P, Richardson PG, Cavo M, et al. Proteasome inhibitors in multiple myeloma: 10 years later[J]. Blood, 2012,120(5):947-959.
  • 5Willis BC, Liebler JM, Luby-Phelps K, et al. Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis[J]. Am J Pathol, 2005,166(5):1321-1332.
  • 6Banas MC, Parks WT, Hudkins KL, et al. Localization of TGF-β signaling intermediates Smad2, 3, 4, and 7 in developing and mature human and mouse kidney[J]. J Histochem Cytochem, 2007,55(3):275-285.
  • 7Zhou L, McMahon C, Bhagat T, et al. Reduced SMAD7 leads to over activation of TGF-beta signaling in MDS that can be reversed by a specific inhibitor of TGF-beta receptor I kinase[J]. Cancer Res, 2011,71(3):955-963.
  • 8Zúiga JE, Groppe JC, Cui Y, et al. Assembly of TbetaRⅠ: TbetaRⅡ: TGFbeta ternary complex in vitro with receptor extracellular domains is cooperative and isoform-dependent[J]. J Mol Biol, 2005,354(5):1052-1068.
  • 9Lasfar A, Cohen-Solal KA. Resistance to transforming growth factor β-mediated tumor suppression in melanoma: are multiple mechanisms in place?[J]. Carcinogenesis, 2010,31(10):1710-1717.
  • 10Kolosova I, Nethery D, Kern JA. Role of Smad2/3 and p38 MAP kinase in TGF-β1-induced epithelial-mesenchymal transition of pulmonary epithelial cells[J]. J Cell Physiol, 2011,226(5):1248-1254.

二级参考文献9

共引文献40

同被引文献14

  • 1韩玉杰,赵松,杨洋,刘东雷,吴恺,潘丽红,朱砾.蛋白酶体抑制剂MG132联合顺铂诱导肺癌A549细胞凋亡的机制[J].中国老年学杂志,2014,34(9):2496-2498. 被引量:2
  • 2普帅,孔瑞瑞,吴瑛.去泛素化酶USP33通过影响Robo1蛋白稳定性介导肺癌细胞中的Slit2信号通路[J].中国病理生理杂志,2015,4(10):1844-1844.
  • 3Chattopadhyay N,Berger AJ,Koenig E,et al.KRAS genotype correlates with proteasome inhibitor ixazomib activity in preclinical in vivo models of colon and Non-Small cell lung cancer:potential role of tumor metabolism[J].PLoS One,2015,10(12):e0144825.DOI:10.1371/journal.pone.0144825.
  • 4Semren N,Habel-Ungewitter NC,Fernandez IE,et al.Validation of the 2nd Generation proteasome inhibitor oprozomib for local therapy of pulmonary fibrosis[J].PLoS One,2015,10(9):e0136188.DOI:10.1371/journal.pone.0136188.
  • 5Ao L,Reichel D,Hu D,et al.Polymer micelle formulations of proteasome inhibitor carfilzomib for improved metabolic stability and anticancer efficacy in human multiple myeloma and lung cancer cell lines[J].J Pharmacol Exp Ther,2015,355(2):168-173.DOI:10.1124/jpet.115.226993.
  • 6Oeshmukh RR.Dou QP.Proteasome inhibitors induce AMPK activation via CaMKKβin human breast cancer cells[J].Breast Cancer Res Treat,2015,153(1):79-88.DOI:10.1007/s10549-015-3512-2.
  • 7Silva KA.Dong J,Dong Y,et al.Inhibition of Stat3 activation suppresses caspase-3 and the ubiquitin-proteasome system,leading to preservation of muscle mass in cancer cachexia[J].J Biol Chem,2015,290(17):11177-11187.DOI:10.1074/jbc.M115.641514.
  • 8Matsunaga T.Yamaji Y,Tomokuni T,et al.Nitric oxide confers cisplatin resistance in human lung cancer cells through upregulation of aldo-keto reductase 1B10 and proteasome[J].Free Radic Res,2014,48(11):1371-1385.DOI:10.3109/10715762.2014.957694.
  • 9Liu J.Shen W,Tang Y,et al.Proteasome inhibitor MG132 enhances the antigrowth and antimetastasis effects of radiation in human nonsmall cell lung cancer cells[J].Tumour Biol,2014,35(8):7531-7539.DOI:10.1007/s13277-014-2012-z.
  • 10王亚伟,欧阳学农,余宗阳.TRAIL联合蛋白酶抑制剂MG132诱导肺癌A549细胞凋亡的实验研究[J].临床肿瘤学杂志,2011,16(4):294-297. 被引量:3

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部